|
Real-time Estimate
Cboe BZX
12:28:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 75.69 USD | -0.66% |
|
-1.62% | +28.57% |
| 07-30 | Ingevity Corporation, Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Ingevity's Q2 Adjusted Earnings Increase, Net Sales Decline; 2026 Adjusted EPS Outlook Raised | MT |
Company Valuation: Ingevity Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,817 | 2,632 | 1,711 | 1,481 | 2,128 | 2,619 | - | - |
| Change | - | -6.55% | -35.01% | -13.42% | 43.69% | 23.06% | - | - |
| Enterprise Value (EV) 1 | 3,791 | 4,028 | 3,082 | 2,814 | 3,259 | 3,596 | 3,490 | 3,433 |
| Change | - | 6.25% | -23.49% | -8.69% | 15.8% | 10.36% | -2.95% | -1.63% |
| P/E | 24.3x | 12.8x | -315x | -3.44x | -12.8x | 18.8x | 12.8x | 11.2x |
| PBR | 4.18x | 3.76x | - | 7.58x | 70.7x | - | - | - |
| PEG | - | 0.1x | 3x | -0x | 0.2x | -0x | 0.3x | 0.8x |
| Capitalization / Revenue | 2.02x | 1.58x | 1.01x | 1.05x | 1.65x | 2.36x | 2.32x | 2.27x |
| EV / Revenue | 2.72x | 2.41x | 1.82x | 2x | 2.53x | 3.24x | 3.09x | 2.98x |
| EV / EBITDA | 8.98x | 8.9x | 7.77x | 7.76x | 8.2x | 9.27x | 8.42x | 8x |
| EV / EBIT | 12.1x | 11.7x | 40.1x | 11.1x | 11.2x | 11.9x | 10.9x | 10.3x |
| EV / FCF | 20x | 23.6x | 32.3x | 55.2x | 11.9x | 15x | 14x | 13.1x |
| FCF Yield | 4.99% | 4.24% | 3.09% | 1.81% | 8.39% | 6.67% | 7.16% | 7.63% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.95 | 5.5 | -0.15 | -11.85 | -4.61 | 4.05 | 5.953 | 6.815 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,392 | 1,668 | 1,692 | 1,406 | 1,289 | 1,110 | 1,130 | 1,153 |
| EBITDA 1 | 422.2 | 452.6 | 396.8 | 362.7 | 397.5 | 388 | 414.7 | 429 |
| EBIT 1 | 312.3 | 343.8 | 76.9 | 254.4 | 291.1 | 302.5 | 319 | 332.5 |
| Net income 1 | 118.1 | 211.6 | -5.4 | -430.3 | -167.1 | 156.9 | 198.6 | 213.5 |
| Net Debt 1 | 974.6 | 1,396 | 1,371 | 1,333 | 1,130 | 977 | 871 | 814 |
| Reference price 2 | 71.70 | 70.44 | 47.22 | 40.75 | 59.18 | 76.19 | 76.19 | 76.19 |
| Nbr of stocks (in thousands) | 39,286 | 37,372 | 36,231 | 36,349 | 35,964 | 34,378 | - | - |
| Announcement Date | 2/23/22 | 2/27/23 | 2/21/24 | 2/18/25 | 2/25/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 18.81x | 3.24x | 9.27x | - | 2.62B | |
| 21.06x | 3.79x | 10.71x | 1.88% | 74.86B | |
| 13.11x | 0.92x | 7.7x | 4.46% | 50.95B | |
| 60.05x | 9.71x | 41.18x | 0.91% | 18.16B | |
| 14.17x | 0.92x | 6.64x | 2.6% | 14.66B | |
| 14.38x | 0.77x | 5.25x | 2.57% | 10.64B | |
| 17.72x | 0.75x | 8.22x | 2.78% | 10.19B | |
| 35.11x | 1.72x | 9.16x | 2.04% | 9.51B | |
| 32.06x | 4.38x | 18.74x | 0.36% | 8.01B | |
| 5.3x | 0.68x | 3.16x | -.--% | 7.3B | |
| Average | 23.18x | 2.69x | 12.00x | 1.96% | 20.69B | |
| Weighted average by Cap. | 22.02x | 2.91x | 11.90x | 2.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NGVT Stock
- Valuation Ingevity Corporation
Select your edition
All financial news and data tailored to specific country editions
